2011 - 13-year renal outcomes varied in patients with type 1 diabetes and new-onset microalbuminuria
- 2011 ->13-year renal outcomes varied in patients with type 1 diabetes and new-onset microalbuminuria. Gutknecht, David R. // ACP Journal Club;7/19/2011, Vol. 155 Issue 1, p12
Questions What are the long-term renal outcomes of patients with type 1 diabetes mellitus (DM) who develop new-onset microalbuminuria? Which factors are associated with poor renal outcomes? Methods Design Randomized Diabetes Control and Complications Trial (DCCT) with its observational extension...
- Does microalbuminuria screening in diabetes prevent complications? Hole, Wayne A.; Nashdsky, Joan // Journal of Family Practice;Mar2003, Vol. 52 Issue 3, p229
This article investigates whether microalbuminuria screening in diabetes prevent complications. Screening diabetic patients from microalbuminuria identifies those who may benefit from treatments that delay progression to renal failure. Diabetic patients have a 20 to 40 percent lifetime risk for...
- Microalbuminuria, glycemic control, and blood pressure predicting outcome in diabetes type 1 and type 2. Mogensen, Carl Erik; Ipoulsen, Per Logstrup // Kidney International Supplement;Nov2004, Issue 92, pS40
Discusses the effect of microalbuminuria, glycemic control and blood pressure on outcome in patients with diabetes. Microalbuminuria in type 1 and 2 diabetes; Predictors of increased mortality; Prognostic significance of microalbuminuria and blood pressure variables.
- Microalbuminuria in diabetes mellitus. Tobe, Sheldon W.; McFarlane, Philip Alan; Naimark, David Malcolm // CMAJ: Canadian Medical Association Journal;9/3/2002, Vol. 167 Issue 5, p499
Reports on microalbuminuria in diabetes mellitus patients. Diagnosis and patients at risk; Incidence of microalbuminuria and effects, including increased risk for cardiovascular and renal disease; Use of antiangiotensin therapy and blood pressure control to reduce urine albumin levels and give...
- The Authors Reply:. Perkins, Bruce A.; Ficociello, Linda H.; Krolewski, Andrzej S. // Kidney International;Nov2010, Vol. 78 Issue 10, p1049
A response by B. A. Parkins and colleagues to a letter to the editor about their article "In patients with type 1 diabetes and new-onset microalbuminuria the development of advanced chronic kidney disease may not require progression to proteinuria," is presented.
- PREVALENCE AND PREDICTORS OF MICROALBUMINURIA IN PATIENTS WITH DIABETES MELLITUS: A CROSS-SECTIONAL OBSERVATIONAL STUDY IN KUMASI, GHANA. Eghan Jr., Benjamin A.; Frempong, Magaret T.; Adjei-Poku, Micheal // Ethnicity & Disease;Autumn2007, Vol. 17 Issue 4, p726
Objective: To evaluate the prevalence and predictors of microalbuminuria in diabetics in Kumasi, Ghana. Design: Prospective, cross-sectional study of diabetic patients. Subjects: Patients with diabetes, 20 to 78 years of age. Main Outcome Measures: Microalbuminuria Methods: All patients (109)...
- Intensive glucose control improves kidney outcomes in patients with type 2 diabetes. Perkovic, Vlado; Heerspink, Hiddo Lambers; Chalmers, John; Woodward, Mark; Jun, Min; Li, Qiang; MacMahon, Stephen; Cooper, Mark E; Hamet, Pavel; Marre, Michel; Mogensen, Carl Erik; Poulter, Neil; Mancia, Giuseppe; Cass, Alan; Patel, Anushka; Zoungas, Sophia // Kidney International;Mar2013, Vol. 83 Issue 3, p517
The effect of intensive glucose control on major kidney outcomes in type 2 diabetes remains unclear. To study this, the ADVANCE trial randomly assigned 11,140 participants to an intensive glucose-lowering strategy (hemoglobin A1c target 6.5% or less) or standard glucose control. Treatment...
- Cost Effectiveness of ACE Inhibitor Treatment for Patients with Type 1 Diabetes Mellitus. Dong, Frederick B.; Sorensen, Stephen W.; Mannien, Diane L.; Thompson, Theodore J.; Narayan, Venkat; Orians, Carlyn E.; Gregg, Edward W.; Eastman, Richard C.; Dasbach, Erik J.; Herman, William H.; Newman, Jeffrey M.; Narva, Andrew S.; Ballard, David J.; Engelgau, Michael M. // PharmacoEconomics;2004, Vol. 22 Issue 15, p1015
Current guidelines recommend treating patients with type 1 diabetes mellitus with ACE inhibitors after the onset of microalbuminuria. Recent clinical trials have shown ACE inhibitors can affect the development of nephropathy when initiated prior to the onset of microalbuminuria. Our objective is...
- Comment on: Hellemons et al. Initial Angiotensin Receptor Blockade--Induced Decrease in Albuminuria Is Associated With Long-Term Renal Outcome in Type 2 Diabetic Patients With Microalbuminuria: A Post Hoc Analysis of the IRMA-2 Trial. Diabetes Care 2011; 34:2078-2083. DAVIDSON, MAYER B. // Diabetes Care;Dec2011, Vol. 34 Issue 12, pe188
A letter to the editor is presented in response to the article "Initial Angiotensin Receptor Blockade-Induced Decrease in Albuminuria is Associated with Long-TermRenal Outcome in Type 2 Diabetic Patients with Microalbuminuria: A Post Hoc Analysis of the IRMA-2 Trial" in the December 2011 issue.